TWD
OLMA icon

True Wealth Design’s Olema Pharmaceuticals OLMA Stock Holding History

True Wealth Design’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$764 Hold
61
– – ﹤0.01% 2074
2026
Q1 		$910 Hold
61
– – ﹤0.01% 1835
2025
Q4 		$1.52K Hold
61
– – ﹤0.01% 1555
2025
Q3 		$598 Buy
61
+52
+578% +$312 ﹤0.01% 1951
2025
Q2 		$39 Sell
9
-32
-78% -$143 ﹤0.01% 2428
2025
Q1 		$155 Buy
+41
New +$206 ﹤0.01% 2050

Other funds holding OLMA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

True Wealth Design's OLMA Position: Q2 2026 in Review

True Wealth Design held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 61 shares worth $764. The position accounts for ﹤0.01% of the portfolio, ranked #2074.

True Wealth Design first reported a position in OLMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.52K in Q4 2025. 10 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • True Wealth Design held 61 shares of Olema Pharmaceuticals worth $764 as of Q2 2026.
  • True Wealth Design left its Olema Pharmaceuticals share count unchanged in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2074 holding.
  • True Wealth Design first reported a position in Olema Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • True Wealth Design's Olema Pharmaceuticals position peaked at $1.52K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.